Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Gara Arteaga-Henríquez

Biographic Data

ID7670157
NAMEGara Arteaga-Henríquez
GIVEN NAMESGara
FAMILY NAMEArteaga-Henríquez
SIGNATUREARTEAGA-HENRÍQUEZ G
AFFILIATIONSDepartment of Psychiatry Hospital Universitari Vall d’Hebron Barcelona Spain
ORCID0000-0002-1251-8988
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Cariprazine Use in Combination With a Mood Stabilizer in First Episode Mania

    Open Access•Roberto Palacios‐Garrán, Roberto Palacios-Garrán et al.•ARTICLE•Frontiers in Psychiatry•2022

    In this sample, cariprazine in combination with mood stabilizers proved to be safe and effective in the treatment of FEM with more than half the patients being adherent to treatment. Therefore, cariprazine add-on is a good choice for promoting the long-term adherence of patients, thus minimizing the risk of relapse and improving prognosis

  • Retrospective symptoms and learning difficulties predicting ADHD in adults

    Open Access•Celestino Rodríguez, Trinidad García et al.•ARTICLE•Scandinavian Journal of Psychology•2021

    People who suffer from ADHD in their childhood are more likely to be involved in criminal acts in late adolescence and adulthood. This study analyses the association between retrospective ADHD symptoms and associated problems (somatic and learning difficulties), and current symptoms in a sample of adults from imprisoned and clinical populations. Four hundred and fifty‐seven participants, aged between 17 and 69 years, were divided into four groups…

  • Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder

    Open Access•Maria S Simon, Bianka Burger et al.•ARTICLE•Frontiers in Psychiatry•2021

    Introduction: Previous research delivers strong indications that inflammatory activation leads to treatment resistance in a subgroup of patients with Major Depressive Disorder (MDD). Thus, tailored interventions are needed. The present study aimed to find potential biomarkers that may enable patients to be stratified according to immune activation. Methods: A phase IIa randomized placebo-controlled trial was performed to assess levels of inflamma…

No prominent works on this page.

  • Retrospective symptoms and learning difficulties predicting ADHD in adults

    Open Access•Celestino Rodríguez, Trinidad García et al.•ARTICLE•Scandinavian Journal of Psychology•2021

    People who suffer from ADHD in their childhood are more likely to be involved in criminal acts in late adolescence and adulthood. This study analyses the association between retrospective ADHD symptoms and associated problems (somatic and learning difficulties), and current symptoms in a sample of adults from imprisoned and clinical populations. Four hundred and fifty‐seven participants, aged between 17 and 69 years, were divided into four groups…

  • Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder

    Open Access•Maria S Simon, Bianka Burger et al.•ARTICLE•Frontiers in Psychiatry•2021

    Introduction: Previous research delivers strong indications that inflammatory activation leads to treatment resistance in a subgroup of patients with Major Depressive Disorder (MDD). Thus, tailored interventions are needed. The present study aimed to find potential biomarkers that may enable patients to be stratified according to immune activation. Methods: A phase IIa randomized placebo-controlled trial was performed to assess levels of inflamma…

  • Cariprazine Use in Combination With a Mood Stabilizer in First Episode Mania

    Open Access•Roberto Palacios‐Garrán, Roberto Palacios-Garrán et al.•ARTICLE•Frontiers in Psychiatry•2022

    In this sample, cariprazine in combination with mood stabilizers proved to be safe and effective in the treatment of FEM with more than half the patients being adherent to treatment. Therefore, cariprazine add-on is a good choice for promoting the long-term adherence of patients, thus minimizing the risk of relapse and improving prognosis

Medicine (3 works) · Psychiatry (3 works) · Mood (2 works) · Psychology (2 works) · Alternative medicine (1 work) · Antidepressant (1 work) · Anxiety (1 work) · Attention Deficit Hyperactivity Disorder (1 work) · Biology (1 work) · Biomarker (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae